Omeros | OMER - Operating Profit

Stock Price
10.44
Daily Change
0.26 2.55%
Monthly
-9.61%
Yearly
22.54%
Q1 Forecast
10.67

Omeros reported $-35.41M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Adma Biologics USD 62.75M 11.74M Dec/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Immunic USD -25.73M 2.91M Sep/2024
Insmed USD -249.71M 11.64M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
MacroGenics USD -12.1M 30.74M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Pacira USD 3.19M 9.96M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Rockwell Medical USD 515K 1.84M Jun/2024
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025
Xoma USD -15.64M 5.56M Sep/2024